Atika Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 64 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 85 |
|
|
2022
Q4 | – | Sell |
-29,000
| Closed | -$2.4M | – | 72 |
|
|
2022
Q3 | $2.4M | Buy |
+29,000
| New | +$2.4M | 0.2% | 57 |
|
|
2020
Q1 | – | Sell |
-42,000
| Closed | -$3.27M | – | 80 |
|
|
2019
Q4 | $3.27M | Buy |
42,000
+18,000
| +75% | +$1.4M | 0.63% | 54 |
|
|
2019
Q3 | $1.76M | Buy |
+24,000
| New | +$1.76M | 0.37% | 55 |
|
|
2016
Q4 | – | Sell |
-102,000
| Closed | -$4.1M | – | 63 |
|
|
2016
Q3 | $4.1M | Buy |
+102,000
| New | +$4.1M | 1.67% | 17 |
|
|
2016
Q2 | – | Sell |
-42,000
| Closed | -$1.23M | – | 58 |
|
|
2016
Q1 | $1.23M | Buy |
+42,000
| New | +$1.23M | 0.75% | 37 |
|
|
2015
Q2 | – | Sell |
-138,000
| Closed | -$3.28M | – | 63 |
|
|
2015
Q1 | $3.28M | Buy |
+138,000
| New | +$3.28M | 2.19% | 14 |
|